Navigation Links
La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial

of 2006 and completion of enrollment is targeted for around the end of 2007.

About Riquent

Riquent is being developed to specifically treat lupus renal disease by preventing or delaying renal flares, a leading cause of sickness and death in lupus patients. Riquent has been well tolerated in all 13 clinical trials, with no serious Riquent-related side effects identified to date. Riquent's only known biological activity is the reduction of circulating levels of anti-dsDNA antibodies. Increases in these antibodies are associated with an increased risk of renal flare. Although clinical benefit has not yet been proven, Riquent treatment has significantly reduced these antibody levels in all clinical trials where they were measured.

About Lupus

Lupus is a chronic, potentially life-threatening autoimmune disease. About 90% of lupus patients are female, and many are diagnosed with the disease during their childbearing years. Approximately 50% of lupus patients have renal disease, which can lead to irreversible renal damage, renal failure and the need for dialysis, and is a leading cause of death in lupus patients. Latinos, African Americans and Asians face an increased risk of serious renal disease associated with lupus. The current standard of care for lupus renal disease often involves treatment with high doses of corticosteroids and immunosuppressive drugs that can cause severe side effects including diabetes, hypertension and sterility, and may leave patients vulnerable to opportunistic infections. To date, no lupus specific drug has been approved in the U.S.

La Jolla Pharmaceutical Company is dedicated to improving and preserving human life by developing innovative pharmaceutical products. The Company's leading product in development is Riquent. The Company has also developed small molecules to treat various other autoimmune and inflammatory conditions. The Company's common stock is traded on The NASDAQ Global Market under the symbol
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent Lupus Phase 3 Trial
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies

Post Your Comments:
(Date:11/25/2009)...-FirstCall/--AmericanScientificResourcesInc.(PinkS...eyhaveopenedaregionalmarketingandproductionmanagem...ecurealocationabroad,providinganessentialgatewayfo...thandsafetyproductsforchildrenandadultstobedistrib...toryinthestateofOhiowheretheywillalsobeabletodosub...
(Date:11/25/2009)...FirstCall/--ERT(Nasdaq: ERES ),announcedtodaythatD...dKeithSchneck,theCompany,sExecutiveVicePresidentan...rayHealthCareConferenceat1:30PMESTonDecember1,2009...ccessthepresentationbyvisitingtheCompany,scorporat...accessedat http://www.corporate-ir.net/ireye/confl...
(Date:11/25/2009)...swire-FirstCall/--Formanyofthemillionsofhearingimp...reated hearingloss ,theholidaysmaynotbeallthathapp...vicepresidentofHearUSA(Amex: EAR ),oneofAmerica,sl...dieshavelinkedhearinglosstostress,frustration,ands...aygatheringswithfamiliesandfriends,whenmanyofthose...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 1Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 2Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 3Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 4Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 5Fabricating 26 Metalworkings Riley Takes Congress to Task on Cap and Trade 56388 1Fabricating 26 Metalworkings Riley Takes Congress to Task on Cap and Trade 56388 2Fabricating 26 Metalworkings Riley Takes Congress to Task on Cap and Trade 56388 3NeoStem to Present at Rodman 26 Renshaws 11th Annual Healthcare Conference 56385 1NeoStem to Present at Rodman 26 Renshaws 11th Annual Healthcare Conference 56385 2NeoStem to Present at Rodman 26 Renshaws 11th Annual Healthcare Conference 56385 3
...il 8 Phase III data, published online this week i...abolism , showed that arzoxifene, an investigation...ing developed by Eli Lilly and Company (NYSE: LL...l hip bone mineral density (BMD) in postmenopausal...o. , , In addition, arzoxifene, dosed at 20 mg/da...
... 7 Scientists at Schepens Eye Research Institute ...a is essential to the health of blood vessels in t...ysfunction. These findings, published in the April... on the prevention and treatment of diseases such ... , , "These results are significant because they ...
Other Medicine Technology:Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density 2Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density 3Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density 4Scientists Discover a Role for the Growth Factor TGF-beta in Maintaining Health of Retinal Blood Vessels 2Scientists Discover a Role for the Growth Factor TGF-beta in Maintaining Health of Retinal Blood Vessels 3
(Date:11/27/2009)...wswire/-- Allrecipes.com , theworld,s#1foodsite,r...orethan2.8millionvisitorsthedaybeforeThanksgiving,...oodholidayoftheyear.TheaverageThanksgivingmealin20...easefromlastyear,sfeast.AccordingtotheAllrecipessi...anksgivingrecipe,acontrastfromlastyear,spopular Ho...
(Date:11/27/2009)...hree new interactive anatomy education apps from M...nd health sciences learning opportunities for iPho...m, NC (Vocus) November 27, 2009 -- Modality, Inc....ivision of Wolters Kluwer Health, today announced ...ps on the App Store. Clemente’s Anatomy, Roh...
(Date:11/26/2009)...rug tetrathiomolybdate (TM) has been shown in stud...ease, a disease caused by an overload of copper, a... Very little, however, is known about how the drug... by Northwestern University researchers now has pr...tructure of TM bound to copper-loaded metallochape...
(Date:11/26/2009)...r. David Kim of the Live Life Again Center, a prac...one of a growing number of physicians who are tak...o connect with individuals who are interested in s...ity. Dr. Kim is utilizing Facebook to share before...ce with the community. , ...
(Date:11/25/2009)...PRNewswire-USNewswire/--Whenmostpeopleheartheacron...lsogivepatientsthehelptheyneed.TMJstandsfortheTemp...contacts/connectswithyourskull(temporalbone). ,...narepainwithchewing,clickingorpoppingofthejaw.Butm...ding:headaches,fatigue,sleepdisturbances,irritabil...
Breaking Medicine News(10 mins):Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
...ailable in French . , It,s a well-documented f...ously aggressive and that boys can be among the wo...ercent of boys will continue to be hyper-aggressiv... , "We know that when the mother faces adverse c...
...minar Tuesday, March 17, 2009, from 8:30 to 9:30 A...nTest, the leading expert in ion channels and GPCR...overy, development, and safety - will feature the ...est,s growing catalog, comprising 86 ion channel a...
... information on this potentially life-threatening ...s Month , , NORTHFIELD, Ill., March 10 Colon can...women in the United States, excluding skin cancer....could save your life or the life of a loved one. ,...
... 2009) -- Health information technology programs i...oning a full two years after being established, an...s, according to a study by investigators at Weill ...ainu Kaushal, chief of the Division of Quality and...
...ch 10 Gundersen Lutheran is the first in the nati...m the National Quality Measures for Breast Centers...resents a commitment to provide the highest level ...der in the measurement of breast cancer treatment ...
...rch 10 A diverse coalition of clergy and lay memb...a press conference today to call on U.S. Senators ...Iowa congressional delegation to support legislati... last session of Congress, Senator Grassley was no...
Other Medicine News:Health News:Perinatal environment influences aggression in children 2Health News:ChanTest to Highlight Expanded Ion Channel and GPCR Services and Cell Lines, Including FDA Critical Path Safety Profiling Tools at ToxExpo, Booth 3056 2Health News:ChanTest to Highlight Expanded Ion Channel and GPCR Services and Cell Lines, Including FDA Critical Path Safety Profiling Tools at ToxExpo, Booth 3056 3Health News:Understand Colon Cancer with MyBiopsy.Org; Schedule a Screening Test at MyHealthTestReminder.Org 2Health News:Understand Colon Cancer with MyBiopsy.Org; Schedule a Screening Test at MyHealthTestReminder.Org 3Health News:New York State health IT strategy may be model for the nation 2Health News:New York State health IT strategy may be model for the nation 3Health News:Gundersen Lutheran Breast Center Earns Top National Honor 2Health News:Faith Leaders Call on Iowa Members of Congress to Support Legislation to Protect Kids from Tobacco 2Health News:Faith Leaders Call on Iowa Members of Congress to Support Legislation to Protect Kids from Tobacco 3
DLP Standard Aortic Root Cannulae
KAVD Venous Cannulae
Select 3D Arterial Cannulae
...offers the vitreoretinal surgeon a temporary tampo...lease of subretinal fluid, dissection of fibro-vas...ng. ,Eftiar Octane and Eftiar Decalin liquid is...ng of the retina. It is also indicated as an aid i...
Medicine Products: